attomarker

UNLOCKING INSIGHTS

IN long covid

At Attomarker Ltd, we are at the forefront of diagnostic innovation, bringing cutting-edge technology to the fight against Long Covid. With our advanced multiplex testing platform, our goal is to provide healthcare providers and patients with precise, reliable, and actionable data to guide treatment decisions and improve quality of life.

Register for Updates

The Diagnostic Challenge

Long Covid presents a complex array of symptoms and underlying mechanisms, making accurate diagnosis and effective management a challenge to professionals. The need for precise, actionable insight is now at a critical level, with Long COVID affecting an estimated 1.8% of the population, and 71% of people with the condition have now had it for more than a year (Long COVID: a clinical update. Greenhalgh et.al. Aug 2024. The Lancet).

Long Covid Antibody Spectrum Test

Attomarker is developing a breakthrough diagnostic solution for Long Covid: the Long Covid Antibody Spectrum Test. The test has just received UKCA Mark approval (January 2025) and is now in the process of being registered with MHRA. It will represent a significant step in helping to understand why an individual has Long Covid and what therapeutic options may provide benefit.

Are there treatment options?

 

The Persistent Virus Theory

Research highlights that for many sufferers, Long Covid symptoms may stem from persistent viral fragments triggering chronic immune activation and dysfunction, with an ‘immunity gap’ preventing the body from clearing these fragments. The Long Covid Antibody Spectrum Test is positioned to help identify these patients and their immunity profiles, so that treatment options may be identified.

How Healthcare Professionals Can Get Involved

Join us in transforming the way Long Covid is diagnosed and managed:

R

Stay Informed

Register to receive updates on our latest developments, including the UKCA Mark approval and launch of the Long Covid Antibody Spectrum Test, and evolving developments in understanding both the condition and treatment options.

R

Participate in Research

Collaborate with Attomarker to advance research on Long Covid and its underlying mechanisms.

Keep Updated

Check out our LinkedIn for the latest updates on Attomarker including our Company Announcements, Investor Announcement and product launches.

Related Studies & Articles